학술논문

Preclinical evaluation of a SARS-CoV-2 mRNA vaccine PTX-COVID19-B.
Document Type
Article
Source
Science Advances. 1/21/2022, Vol. 8 Issue 3, p1-15. 15p.
Subject
*COVID-19
*COVID-19 vaccines
*MONOCLONAL antibodies
*VIRAL envelope proteins
*INTERLEUKIN-4
Language
ISSN
2375-2548
Abstract
The article offers information on preclinical evaluation of a SARS-CoV-2 mRNA vaccine PTX-COVID19-B. It mentions that tests in mice and hamsters indicated that PTX-COVID19-B induced robust humoral and cellular immune responses and completely protected the vaccinated animals from SARS-CoV-2 infection in the lung.